CD07805/47 Gel

DRUG3 trials

Sponsors

Galderma R&D

Conditions

Rosacea

Phase 2

Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

CompletedNCT01174030

Galderma R&DRosacea

Start: 2010-08-31End: 2011-01-31Updated: 2021-02-26

Phase 3

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

CompletedNCT01355471

Galderma R&DRosacea

Start: 2011-05-31End: 2012-01-31Updated: 2021-02-18

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

CompletedNCT01355458

Galderma R&DRosacea

Start: 2011-05-31End: 2011-12-31Updated: 2021-02-18